{"url":"https://lda.senate.gov/api/v1/filings/e9c00a8d-1e9c-4f28-941c-fe9d64ae05a8/","filing_uuid":"e9c00a8d-1e9c-4f28-941c-fe9d64ae05a8","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2009,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e9c00a8d-1e9c-4f28-941c-fe9d64ae05a8/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Barry Lefkowitz, President","dt_posted":"2009-04-17T10:39:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5 Azalea Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Lumberton","registrant_state":"NJ","registrant_zip":"08048","registrant":{"id":58693,"url":"https://lda.senate.gov/api/v1/registrants/58693/","house_registrant_id":35062,"name":"MANAGEMENT & GOVERNMENT RESOURCES","description":"Lobbying and Economic Development","address_1":"5 Azalea Drive","address_2":null,"address_3":null,"address_4":null,"city":"Lumberton","state":"NJ","state_display":"New Jersey","zip":"08048","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BARRY LEFKOWITZ","contact_telephone":"+1 609-267-2855","dt_updated":"2022-04-06T16:07:46.512326-04:00"},"client":{"id":160681,"url":"https://lda.senate.gov/api/v1/clients/160681/","client_id":87,"name":"PUREST COLLOIDS","general_description":"Manufacturer of minerals and nutrients","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-23"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FDA, EPA regulations dealing with colloidal minerals Manufacture\nPharmacy\nScience, technology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46446,"prefix":"mr","prefix_display":"MR.","first_name":"BARRY","nickname":null,"middle_name":"E","last_name":"LEFKOWITZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}